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Background: For their application in the area of diagnosis and therapy, single-domain antibodies (sdAbs) offer
multiple advantages over conventional antibodies and fragments thereof in terms of size, stability, solubility,
immunogenicity, production costs as well as tumor uptake and blood clearance. Thus, sdAbs have been identified
as valuable next-generation targeting moieties for molecular imaging and drug delivery in the past years. Since
these probes are much less complex than conventional antibody fragments, bacterial expression represents a facile
method in order to produce sdAbs in large amounts as soluble and functional proteins.
Results: By the combined use of high cell density cultivation media with a genetically engineered E. coli mutant
strain designed for the cytoplasmic formation of proper disulfide bonds, we achieved high level of intracellular
sdAb production (up to 200 mg/L). Due to a carboxyterminal hexahistidine epitope, the soluble recombinant sdAbs
could be purified by one-step immobilized metal affinity chromatography to apparent homogeneity and easily
radiolabeled with 99mTc within 1 h. The intradomain disulfide bridge being critical for the stability and functionality
of the sdAb molecule was shown to be properly formed in ~96% of the purified proteins. In vitro binding studies
confirmed the high affinity and specificity of the expressed sdAb 7C12 towards its molecular target.
Conclusions: Our study demonstrates an efficient cultivation and expression strategy for the production of
substantial amounts of soluble and functional sdAbs, which may be adopted for high-yield production of other
more complex proteins with multiple disulfides as well.Background
In a variety of solid tumors, including head and neck,
breast, non-small-cell lung and pancreatic cancer, mem-
bers of the human epidermal growth factor receptor fam-
ily are overexpressed and/or deregulated [1-4]. The most
prominent members of this family, EGFR and HER-2, rep-
resent validated targets for anticancer therapy and the
current successful approaches include (i) antibodies such as
Cetuximab (ImClone) and Panitumumab (Amgen) binding
the extracellular ligand binding domain (ECD) as well as
(ii) small molecule tyrosine kinase inhibitors (TKIs) such
as Gefitinib (Astra-Zeneca) and Erlotinib (Roche) [5]. The
former therapy prevents EGFR ligands from interacting
and activating the receptor as well as receptor-ligand* Correspondence: k.zarschler@hzdr.de
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reproduction in any medium, provided the orinternalization, whereas the latter approach focuses on
blocking adenosine triphosphate binding to the intracel-
lular TK domain of EGFR, thereby inhibiting TK activity
and subsequent intracellular signaling [6,7].
Within the last ten years, small recombinant antibody
fragments have gained importance in the area of antibody-
based anticancer therapies and diagnostics [8-11]. Single-
domain antibodies (sdAbs), which are derived from camelid
heavy chain-only antibodies and which consist solely of
the antigen-specific domain [12], offer multiple advantages
over conventional antibodies and fragments thereof in
terms of size, stability, solubility as well as tumor uptake
and blood clearance [13,14]. Several research groups
described recently the construction, selection, and use
of EGFR-binding sdAbs for tumor targeting, active drug
delivery and radioimmunodetection of EGFR overexpress-
ing tumors [15-18]. Both sdAbs investigated in this study,
7C12 and EG2, showed affinities to recombinant EGFRal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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resonance [16,17]. Binding of 7C12 to EGFR-presenting
A431 cells could be blocked in vitro and in vivo by the
addition of Cetuximab [17,19], suggesting that both anti-
body formats bind to overlapping or adjacent epitopes on
the receptor. Furthermore, Roovers and colleagues identi-
fied 7C12 as EGF antagonist that inhibits EGF-induced
phosphorylation of EGFR dose dependently [20]. However,
no effector function such as ligand-competitive inhibition
of EGFR activation has been described for EG2.
The recombinant production of the intramolecular
disulfide containing sdAbs has mainly been achieved
by periplasmic and cytoplasmic expression using bacteria
[21,22] or by expression and targeting to the secretory
pathway of yeast [23,24]. However, methods for the pro-
duction of sdAbs in transgenic plants [25], mammalian
cell lines [26] and insect cells [27] have been described
recently as well. Since every expression system has its
advantages, limitations and drawbacks [28,29], we focus
on the efficient disulfide bond formation as well as the
obtainment of a high level of soluble and correctly folded
product. Both issues are of special importance for eco-
nomic large-scale production of sdAbs for their direct
application in therapy and diagnosis or their further func-
tionalization with nanoparticles and other surfaces [30-32].
In this study we report on the high-yield production
of functional soluble single-domain antibodies in the
cytoplasm of E. coli. Therefore, we use a genetically
engineered double mutant strain defective in both, the
thioredoxin (trxB) and glutathione (gor) pathways, which
constitutively expresses the disulfide bond isomerase DsbC
in the cytoplasm [33]. In combination with an enzyme-
based glucose release system for fed-batch-like cultivation
conditions, we obtain growth to higher cell densities,
improved recombinant protein expression and excellent
yields of up to 200 mg/L native, biologically active sdAb.
Results
Cloning of the sdAb open reading frames
The codon-optimized coding sequences of EGFR-specific
sdAbs 7C12 and EG2 originating from the published
amino acid sequences were cloned into the E. coli expres-
sion plasmid pET-28b for cytoplasmic localization of the
recombinant proteins. In both cases, the sequence encod-
ing a hexahistidine epitope was translationally fused to the
carboxyterminal region of the sdAbs to facilitate further
purification, radiolabeling and immunological detection. A
start codon for the initial methionine was introduced by
the NcoI restriction site used for cloning. The sdAb coding
sequences were under control of the T7 promoter and
their expression was induced using IPTG. The putative
proteins contain two cysteine residues forming an intrado-
main disulfide bridge [34], as highlighted in Figure 1. Pro-
tein sequence alignment revealed a sequence similarity ofboth sdAbs of 80.4% and differences by several amino acid
substitutions in each complementary determining region
(CDR), which are involved in antigen binding [35].
Cultivation characteristics in different media
During the cultivation of E. coli SHuffle® T7 Express har-
boring the recombinant constructs pET-28b:7C12 or pET-
28b:EG2 in Luria-Bertani (LB) broth, Terrific broth (TB)
or EnPresso medium, respectively, growth characteristics
and medium pH conditions were recorded and summa-
rized in Table 1. Bacterial cultures grown in EnPresso
medium showed higher induction and final cell densities
compared to LB and TB media. With respect to buffer
capacities, the EnPresso medium was capable of maintain-
ing pH between 6.5 and 7.0 throughout the cultivation,
while in LB and TB media pH increased above 8 during
prolonged cultivation. However, independently from the
different cultivation media, cell densities of the strain har-
boring pET28b:EG2 were somewhat higher than those of
the strain carrying pET-28b:7C12.
Figure 2 presents the detailed cell density and pH data
for the strain transformed with pET-28b:7C12. The use
of different cultivation media had remarkable influence
on the cell density of the culture, whereas the EnPresso
medium was superior to the other media. The final OD600
at 24 h after induction was ~13 in EnPresso medium,
whereas in LB and TB cultures the final OD600 at the
time point of harvest were ~1.4 and ~8.3, respectively.
Recombinant protein production
Total and soluble protein fractions of recombinant strains
at 24 h after induction separated by SDS-PAGE are visual-
ized in Figure 3A. For the strains E. coli SHuffle® T7
Express [pET-28b:7C12] and SHuffle® T7 Express [pET-
28b:EG2] cultured in the three different media, similar
protein productivities were observed. In all of these cul-
tures most of the expressed sdAbs were in the soluble
form as suggested by the virtually equal sizes of total and
soluble sdAb bands.
Immunological detection using an antibody directed
against the carboxyterminal hexahistidine epitope of the
recombinant proteins led to a single band confirming
the results of the SDS-PAGE (Figure 3B).
Purification of the recombinant single-domain antibodies
In order to quantify the amount of cytoplasmically
expressed sdAb in different media, 50 mL of each cul-
ture were harvested at 24 h after induction, purified by
immobilized metal affinity chromatography (IMAC),
and the amount of purified protein was determined col-
orimetrically. Although cultivation of E. coli SHuffle® T7
Express in EnPresso media resulted in the highest cell
density and calculated cellular dry weight at the time
point of harvest, no significant differences in the amount
Figure 1 Protein sequence alignment of investigated single-domain antibodies. The amino acid sequences of sdAbs 7C12 and EG2 were
aligned using the EMBOSS Pairwise Alignment Algorithms. The two cysteine residues forming an intradomain disulfide bridge are highlighted
in red.
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EnPresso media and TB (Figure 4). However, the amount
of purified recombinant protein differed between the
studied sdAbs. For 7C12, on average, the protein product-
ivity is ~120 mg/L and ~130 mg/L for TB and EnPresso
media, respectively, whereas ~13 mg/L recombinant sdAb
where achieved for LB broth. The average productivity
of EG2 was higher in each investigated culture medium
compared to 7C12, ranging from 37 mg/L for LB broth
to ~175 mg/L and ~200 mg/L for TB and EnPresso
media, respectively.
For the standard protein expression strain E. coli BL21
(DE3) cultivated in EnPresso media, the recombinant
protein productivity was slightly higher compared to
E. coli SHuffle® T7 Express. An amount of ~220 mg EG2
and ~140 mg 7C12 could be purified from 1 L of EnPresso
media, respectively, representing an approximately 10%
higher production yield.
Analysis of free sulfhydryl and disulfide groups
Since the intradomain disulfide bridge is critical for
the stability and functionality of the sdAb molecule,
we quantified the fraction of oxidized cysteine residues
in the purified proteins expressed either in the cytoplasmTable 1 Growth and pH characteristics of different E. coli cult
Strain Medium OD600 at induction pH at
SHuffle® T7 Express [pET-28b:7C12] LB 1.0
TB 1.1
EnPresso 10.6
SHuffle® T7 Express [pET-28b:EG2] LB 1.0
TB 1.0
EnPresso 10.2
Samples from each cultivation were taken at the time point of induction and harve
was calculated at the end of cultivation, whereas one unit of OD600 corresponds toof E. coli SHuffle® T7 Express or in E. coli BL21(DE3). As
described above, the former represents an engineered
strain to promote disulfide bond formation in the cyto-
plasm, whereas the latter is a standard strain for protein
production.
The results summarized in Table 2 show that most
of the sdAbs from EnPresso cultures are present as
oxidized proteins after expression in the cytoplasm of
E. coli SHuffle® T7 Express and purification. Only ~80% of
the sdAbs exist as oxidized proteins after purification,
if E. coli BL21(DE3) is used as expression host. Thermal
unfolding of sdAbs expressed in different E. coli strains
revealed, that lack of a disulfide bonds is consistent with
lower thermal stability. As shown in Table 2, the melting
temperatures of sdAbs expressed in SHuffle® T7 Express
are increased compared to identical proteins generated
in BL21(DE3).
Ten μg of purified sdAbs expressed in E. coli SHuffle®
T7 Express were analyzed further by SDS-PAGE with or
without prior reduction, and subsequently transferred
onto a PVDF membrane for Western Blot analysis using
an antibody directed against the carboxyterminal hexa-
histidine epitope (Figure 5). Colloidal Coomassie and im-
munostaining of unreduced sdAbs revealed the existenceures
induction OD600 at harvest pH at harvest CDW (g/L) at harvest
7.3 1.4 8.8 0.38
7.2 8.3 8.4 2.24
6.5 13.1 6.9 3.54
7.3 1.8 8.7 0.49
7.1 10.7 8.1 2.89
6.6 19.8 7.0 5.35
st and subsequently, OD600 and pH were determined. Cell dry weight (CDW)
a dry cell weight of 0.27 g/L [52].
Figure 2 Recorded data during cultivation of recombinant E. coli strain SHuffle® T7 Express [pET-28b:7C12] in different culture media.
Cell density (A) and pH (B) measurements for EnPresso medium (EN), Luria-Bertani medium (LB) and Terrific Broth (TB). The time point of
induction (1 mM IPTG) is highlighted with a dashed vertical line. Cultures in LB and TB were grown for 6 h at 30°C before induction, whereas
EnPresso cultures were grown for 24 h at 30°C before induction. All cultures were harvested 24 h after induction. The cultivation experiment was
repeated twice and average values are shown.
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of ~25 kDa. These results prove the oxidation of thiol
groups and the predominant formation of an intradomain
disulfide bridge, if the sdAbs are expressed in the cyto-
plasm of E. coli SHuffle® T7 Express.
Radiolabeling and cell binding studies
Purified sdAbs from E. coli SHuffle® T7 Express were
radiolabeled by incubating [99mTc(H2O)3(CO)3]
+ with the
proteins (100 μg; 1 μg/μL) at 37°C for up to 60 min.
Within this time period, a radiochemical yield of >98%
(as analyzed by radio-TLC) was obtained and longer
incubation times did not improve the radiochemical
yield (Figure 6A). Radiolabeled proteins were analyzed
by SDS-PAGE (Figure 6B) and autoradiography (Figure 6C)
in the absence of dithiothreitol. A single predominantprotein species corresponding to the monomeric radi-
olabeled sdAb is clearly visible in the Coomassie stained
gels as well as in the autoradiographic images.
In order to evaluate the binding specificity and affinity
of cytoplasmically expressed sdAbs to human EGFR, two
dimensional cell cultures of epidermoid carcinoma (A431),
squamous carcinoma (FaDu) and ductal carcinoma (MDA-
MB 435S) cells were incubated with radiolabeled sdAbs.
These tumor cell lines present different expression levels
of the receptor on their cell surface as determined by
quantitative immunostaining (Figure 7A). EGFR abun-
dance is significantly elevated in A431 cells and moderate
in FaDu cells, whereas MDA-MB 435S cells contain no
detectable amount of the receptor.
To gain insight into the epitope specificity of investi-
gated sdAbs, EGFR was blocked with a 40-fold excess of
Figure 3 Recombinant protein production of recombinant E. coli strains SHuffle® T7 Express [pET-28b:7C12] and [pET-28b:EG2] using
different cultivation media. Total and soluble protein fractions of recombinant strains at 24 h after induction separated by SDS-PAGE with
subsequent Coomassie staining (A) or immunological detection using an HRP-conjugated Penta His antibody directed against the hexahistidine
epitope (B). In order to allow direct comparison between different cultivation media, all samples were diluted depending to their optical density
to equal cell concentration before cell lysis and gel loading. LB = Luria-Bertani broth, TB = Terrific broth, EN = EnPresso medium, T = total cell
lysate, S = soluble fraction of cell lysate. The experiments were repeated twice and representative pictures are shown.
Zarschler et al. Microbial Cell Factories 2013, 12:97 Page 5 of 13
http://www.microbialcellfactories.com/content/12/1/97unlabeled Cetuximab before adding radiolabeled sdAbs
(Figure 7B). Binding of 99mTc-7C12 with A431 and FaDu
cells is EGFR-specific as it could be blocked substantially
by Cetuximab. However, 99mTc-EG2 binding was only
slightly reduced by pre-incubation of cells with Cetuxi-
mab. This observation indicates that 99mTc-EG2 recog-
nizes an epitope not overlapping with that of Cetuximab.
Based on these results, 99mTc-7C12 was selected for fur-
ther analysis of EGFR binding. In Figure 7C, the saturation
binding curves of 99mTc-7C12 for the EGFR-positive cell
lines A431 and FaDu are shown. Scatchard analysis
were applied to calculate a Kd of 23 ± 5 nM and Bmax of
16 pmol/mg protein for A431 and a Kd of 13 ± 4 nM
and Bmax of 3 pmol/mg protein for FaDu cells, respect-
ively. For the EGFR-negative cell line MDA-MB 435S,
no specific binding could be observed.
Discussion
As the vast majority of antibodies, single-domain anti-
bodies (sdAbs) contain cysteine residues forming disulfideFigure 4 Production yield of sdAbs in E. coli SHuffle® T7 Express [pET
yield obtained for expressed sdAbs. All cultures were grown in triplicate anbonds, whose presence is crucial for the stability and
functionality of the sdAb molecules. Hence, the correct
formation of the S-S bond and the associated proper
folding of the soluble sdAb monomers appear to be at
least as important for their application in the fields of
tumor targeting and drug delivery as their high yield
production. Bacterial cysteine oxidation occurs predom-
inantly after a protein has been secreted from the highly
reducing environment of the cytoplasm into the more
oxidizing periplasm, requiring a bacterial leader peptide.
However, this strategy often suffers from low yields of
active protein due to poor translocation across the cyto-
plasmic membrane as well as aggregation in the periplasm
[36]. In order to address these problems, genetically engi-
neered double mutant strains defective in both, the
thioredoxin and glutathione pathways, have been devel-
oped [37,38]. These mutations render the cytoplasm
more oxidizing, allowing the formation of structural disul-
fide bonds in this compartment. Furthermore, the con-
stitutive cytoplasmic expression of the disulfide bond-28b:7C12] and [pET-28b:EG2]. Comparison of protein production
d the reported values correspond to the average.
Table 2 Quantification of oxidized cysteine residues in purified sdAbs and corresponding melting temperatures
Protein Strain Medium % oxidized cysteine residues Tm [°C]
7C12 SHuffle® T7 Express EnPresso 96.1 ± 0.6 64.8 ± 0.8
BL21 (DE3) EnPresso 84.7 ± 1.1 61.0 ± 1.0
EG2 SHuffle® T7 Express EnPresso 97.6 ± 0.5 60.5 ± 0.5
BL21 (DE3) EnPresso 81.2 ± 0.7 58.9 ± 0.7
Purified sdAbs from EnPresso cultures were denatured and incubated with (Sred) or without (Sox) tris(2-carboxyethyl)phosphine. After removal of the reducing
agent by acetone precipitation, proteins were incubated with Ellman’s reagent. The formation of 2-nitro-5-thiobenzoate was quantified in a spectrophotometer by
measuring the absorbance at 412 nm (A412nm), and the percentage of oxidized cysteine residues was calculated using the formula: 100% - 100 * A412nm[Sox]/
A412nm[Sred]. Thermal unfolding was assessed at pH 7.4 by measuring the absorbance at 280 nm as a function of temperature.
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eine containing proteins [33,39]. Herein, we compared
the efficiency of protein production for two EGFR-
specific sdAbs in the cytoplasm of the commercially
available trxB gor mutant strain E. coli SHuffle® T7
Express between three different cultivation media. In
addition to Luria-Bertani (LB) and Terrific broth (TB),
we used an enzyme-based glucose release system (EnPresso
medium) for cytoplasmic expression of sdAbs. As observed
earlier by Krause and colleagues [40], considerably higher
cell densities are obtained with the EnPresso medium com-
pared to LB and TB (Figure 2). Most of the recombinant
cytoplasmic proteins are produced in the soluble fraction.
Surprisingly, the cytoplasmic productivity per cell of total
and especially soluble protein was similar between the dif-
ferent media, but due to substantially higher cell densities,
TB and EnPresso media outperform LB. Comparative puri-
fication of cytoplasmically expressed sdAb originating from
the complete biomass of a 50-mL culture resulted in 100–
200 mg/L soluble sdAb for TB and EnPresso media and
five to ten times less recombinant protein for LB media
(Figure 4). This is in excellent agreement with published
expression data with microbial protein productivity of
100 mg/L for E. coli [41-43] and up to 100 mg/L for
Saccharomyces cerevisiae [23,44,45]. Differences in pro-
tein productivity between 7C12 and EG2 suggest that
the overall production yield is strongly depended on
the antibody of interest [46]. The standard protein ex-
pression strain E. coli BL21(DE3) shows slightly higher
production levels compared to the trxB gor mutant
strain E. coli SHuffle® T7 Express. This observation
might be explained by the additional constitutive ex-
pression of the disulfide bond isomerase DsbC in the
cytoplasm of the latter strain, which limits the readily
available protein production machinery for recombin-
ant proteins.
As described for sdAbs, functional formats of conven-
tional antibodies such as antigen binding fragments (Fabs)
and single-chain variable regions (scFvs) can be expressed
using E. coli either in the cytoplasm or in the periplasm
[46-48]. Intracellular overexpression of antibody frag-
ments often results in insoluble aggregates (inclusion
bodies) and periplasmic expression generally suffers fromlow yields. The use of mutant strains that promote di-
sulfide bond formation in the cytoplasm also represents
for these antibody derivatives a successful and economic
strategy to produce recombinant antibodies with pro-
tein productivities of up to 30 mg/L [49-51].
As shown here, there are no substantial differences
in the protein productivity of E. coli cultures grown in
rather simple media such as TB or 2YT compared to
complex high cell density cultivation media. However,
the former media do not feature the pH maintenance
capacity of EnPresso media, which is of special import-
ance for long term and economic large scale produc-
tion as carried out in industrial applications.
Higher expression levels of correctly folded recombinant
antibody fragments may be achieved by modifying the
culture conditions such as temperature and oxygen
transfer. For example, Ukkonen and co-workers were
able to increase the cell density as well as the active yield
of a recombinant enzyme expressed in E. coli by the com-
bined use of EnPresso medium and high-aeration shake
flasks [52].
Characterizations of the cytoplasmically expressed
and purified sdAbs demonstrate that the vast majority of
the cysteine residues are in the oxidized state and almost
no sdAb dimers are detectable (Table 2 and Figure 5).
These results indicate that the desired intradomain S-S
bond within the sdAb monomer is formed favorably
over an aberrant intermolecular disulfide between two
sdAb molecules. This is most likely attributable to the
rather slow kinetics of protein oxidation in the cyto-
plasm as already discussed by Bessette and co-workers
for the oxidation of alkaline phosphatase in the cyto-
plasm of a comparable E. coli strain. According to the
authors, at slow oxidation rates, the native conform-
ation of the recombinant protein determines the disul-
fide bond formation and leads to bridging of the proper
cysteine residues [33]. Interestingly, a substantial frac-
tion of oxidized sdAbs expressed in the reducing cyto-
plasm of the standard expression host E. coli BL21(DE3)
could be detected. Similar findings were already described
in literature, e.g. Järviluoma and colleagues purified com-
parable amounts of functional sdAb derivative from E. coli
BL21(DE3) and from trxB gor mutant Origami(DE3) cells
Figure 5 Analysis of purified sdAbs under reducing and
non-reducing conditions. Ten μg of purified sdAbs 7C12 (lane 1
and 3) and EG2 (lane 2 and 4) generated in E. coli SHuffle® T7 Express
were analyzed by SDS-PAGE in the absence and presence of the
reducing agent dithiothreitol (DTT) with subsequent Coomassie
staining (A) or immunological detection using a HRP-conjugated
Penta · His antibody directed against the hexahistidine epitope (B). A
weak band corresponding to sdAb dimer is highlighted by an arrow.
SDS-PAGE and immunostaining were repeated twice and
representative pictures are shown.
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are oxidized spontaneously during purification procedure
by atmospheric oxygen [54]. However, random oxidation
of proteins possessing more than one S-S bond results
in scrambled disulfides, which may require complicated
rearrangement. The decreased amount of oxidized sdAbsoriginating from BL21(DE3) cultures is consistent with
the lower thermal stability (Table 2). Since disulfide bonds
increase the conformational stability of proteins consider-
ably [55], sdAbs with free thiol groups unfold at lower
temperature. This underlines the importance of correct
S-S bond formation and the associated proper folding of
the soluble sdAb monomers.
In order to proof the functionality of the expressed
sdAbs, we radiolabeled the purified proteins with 99mTc and
investigated specific binding to human EGFR-expressing
tumor cells (Figures 6 and 7). The expressed sdAbs
recognize non-overlapping epitopes of the receptor,
since 99mTc-7C12 competes for binding to EGFR with
the whole antibody Cetuximab and 99mTc-EG2 does not.
The reported affinities of 99mTc-7C12 of 2.3 nM [17]
and 3.7 nM [19] differ from that we obtained here. The
main reason therefore might be the method of measure-
ment. Gainkam and colleagues determined the affinity
of 7C12 either to soluble recombinant EGFR by surface
plasmon resonance [17] or to A431 cells in PBS [19],
whereas here a binding assay to full-length EGFR pre-
sented by living cells in the presence of serum was ap-
plied. Since in vivo serum proteins [56], in particular
endogenous ligands of the targeted receptor (e.g. epider-
mal growth factor (EGF), betacellulin, heparin-binding
EGF-like growth factor, and transforming growth factor-
α) compete with the sdAbs for binding to EGFR, the
obtained affinities are supposed to be closer to in vivo
reality. The surprising variety in the affinity of the
sdAbs between A431 and FaDu cells can be explained
by the different cellular context as it was observed simi-
larly for EGF recently [57].
Conclusions
Here we demonstrated, for the first time, the combined
use of high cell density cultivation media with a genetic-
ally engineered E. coli mutant strain designed for the
cytoplasmic formation of proper disulfide bonds for the
production of up to 200 mg/L functional soluble single-
domain antibodies (sdAbs). The ability to produce
substantial amounts of correctly folded recombinant
sdAbs as well as tailor-made multispecific and multi-
valent derivatives thereof in E. coli paves the way for
their application in the fields of tumor targeting, molecu-
lar imaging and drug delivery. In addition, the promising
cultivation and expression conditions used in this study
could be adopted for high-yield production of other more
complex proteins with multiple disulfides as well.
Methods
E. coli strains and plasmids
Escherichia coli NEB 5-alpha (fhuA2 Δ(argF-lacZ)U169
phoA glnV44 Φ80Δ (lacZ)M15 gyrA96 recA1 relA1
endA1 thi-1 hsdR17) was used in molecular cloning
Figure 6 Radio-TLC, SDS-PAGE and autoradiography analysis of 99mTc-labeled sdAbs. After radiolabeling of 7C12 at its carboxyterminal
hexahistidine epitope with [99mTc(H2O)3(CO)3]
+, the radiochemical yield was determined by radio-TLC (A). Identical graphs were obtained for EG2
and are therefore not shown. 99mTc-sdAbs were further analyzed by SDS-PAGE (B) and autoradiography (C) in the absence of DTT. The protein
contents were visualized by Coomassie staining. Radiolabeling, SDS-PAGE and autoradiography analysis were repeated twice and representative
pictures are shown.
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lacZ::T7 gene1 [lon] ompT ahpC gal λatt::pNEB3-r1-
cDsbC (SpecR, lacIq) ΔtrxB sulA11 R(mcr-73::miniTn10–
TetS)2 [dcm] R(zgb-210::Tn10 --TetS) endA1 Δgor Δ
(mcrC-mrr)114::IS10) and E. coli BL21(DE3) (fhuA2 [lon]
ompT gal (λ DE3) [dcm] ΔhsdS) were used for ex-
pression of the recombinant sdAb. All strains were
purchase from New England Biolabs. The plasmid
pET-28b (Merck KGaA) coding a kanamycin resistance
was used for cytoplasmic protein production.Bacterial media
In this study, three different media were used for the
cultivations: (i) Luria-Bertani broth (LB), (ii) Terrific broth
(TB) and (iii) EnPresso medium (EN). Luria-Bertani broth
contained (per liter): 10 g tryptone, 5 g yeast extract and
5 g sodium chloride. Terrific broth contained (per liter):
12 g tryptone, 24 g yeast extract, 4 mL glycerol, 100 mL
0.17 M KH2PO4, and 100 mL 0.72 M K2HPO4. EnPresso
medium (BioSilta) was prepared as described by the
manufacturer [40]. Briefly, in a 1 L shaking flask, four
Figure 7 Analysis of EGFR expression levels and binding affinities of sdAbs to human EGFR-presenting cells. Whole-cell lysates of
exponentially growing cells (A431, FaDu, MDA-MB 435S) were prepared and equal amounts of total cellular proteins were separated by SDS-PAGE
on 10% polyacrylamide gels. After Western Blot transfer onto PVDF membranes, EGFR and β-actin proteins were detected by incubation with the
respective specific antibodies followed by HRP-coupled antibodies and chemiluminescence detection (A). In vitro specificity of 99mTc-7C12 and
99mTc-EG2 on A431 and FaDu cells was investigated after 1 h incubation on ice (B). Binding of radiolabeled sdAbs was blocked by 40-fold excess
of unlabeled Cetuximab. Binding data is expressed as percent of injected dose per mg protein (% ID/mg protein). NB = non-blocked, B = blocked. For
in vitro binding studies, two dimensional cultures of A431, FaDu and MDA-MB 435S cells were incubated with increasing concentrations of 99mTc-7C12
(C). Total binding was measured in the absence of and nonspecific binding in the presence of 1 mM unlabeled sdAb. Specific binding was calculated
as the difference between total and nonspecific binding. Binding studies were repeated twice and representative saturation curves for the
EGFR-positive cell lines A431 and FaDu are shown. For the EGFR-negative cell line MDA-MB 435S, no specific binding was observed.
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sterile water. Before inoculation, the glucose releasing
enzyme was added to a final concentration of 0.3 U/L.
Before induction of protein expression with IPTG, theaddition of two EnPresso booster tablets results in a
higher concentration of complex nutrients [52].
All media were supplemented with 50 μg/mL kanamy-
cin sulphate for maintaining the selective pressure.
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For binding and uptake studies, three different adherent
human tumor cell lines were used: the epidermoid car-
cinoma cell line A431 (ATCC® Number: CRL-1555), the
squamous cell carcinoma cell line FaDu (ATCC® Number:
HTB-43), the ductal carcinoma cell line MDA-MB 435S
(ATCC® Number: HTB-129). All cells were cultured in
T25 or T75 cell culture flasks in 6 or 12 mL DMEM plus
10% heat-inactivated fetal calf serum (FCS), respectively,
and incubated in a humidified atmosphere of 95% air/5%
CO2 at 37°C. For harvesting, counting and sub-cultivation,
culture media was removed and cells were washed twice
with PBS. After the addition of 1% trypsin-EDTA, cells
were incubated for 5 min at 37°C in order to detach from
the bottom of the culture flask. Then, DMEM plus 10%
FCS was added and cell suspension was transferred into
50-mL conical centrifuge tubes and spun down for 5 min
at 150 × g and room temperature. The cell pellet was
resuspended in 10 mL DMEM plus 10% FCS and the
cell number as well as viability was determined using a
CASY cell counter (Roche Diagnostics) according to the
manufacture’s protocol. All cell lines were confirmed to
be mycoplasma negative using the LookOut myco-
plasma PCR detection kit (Sigma-Aldrich) and were
tested monthly.
Sequence analysis
For in silico reverse translation of amino acid sequences
the Sequence Manipulation Suite was used [58]. Physical
and chemical parameters of sdAbs were calculated with
the ProtParam tool [59]. The EMBOSS Pairwise Align-
ment Algorithms were used for pairwise alignments of
protein sequences [60].
Molecular cloning
The sdAb coding sequences were commercially synthe-
sized including a 5′ restriction site for NcoI and a 3′ re-
striction site for HindIII, respectively. The ~380-nt DNA
fragments were digested with appropriate restriction en-
donucleases and ligated into NcoI/HindIII-linearized pET-
28b plasmid. The ligation reactions were transformed into
chemically competent E. coli NEB 5-alpha cells. The DNA
sequences of the resulting recombinant constructs pET-
28b:7C12 and pET-28b:EG2 were checked by automated
DNA sequencing.
Cultivation and expression of recombinant proteins
Freshly transformed E. coli SHuffle® T7 Express and
E. coli BL21(DE3) harboring the recombinant plasmids
pET-28b:7C12 or pET-28b:EG2 were inoculated in 5 mL
of LB broth containing 50 μg/mL of kanamycin and cul-
tivated at 30°C for overnight in an orbital shaker with
50 mm offset and shaking speed of 200 rpm. After that,
1 mL of this pre-culture was inoculated into 100 mLEnPresso medium in 1000 mL conical glass flasks and
grown at 30°C. After overnight cultivation, two EnPresso
booster tablets and an additional dose of the glucose re-
leasing enzyme (0.6 U/L) were added to each 100 mL
culture. At the same time, recombinant protein expres-
sion was induced by the addition of 1 mM IPTG. Culti-
vation was continued as described above for 24 h.
For comparison purposes, recombinant protein pro-
duction in standard LB and TB broth, respectively, was
tested under similar cultivation conditions as described
for the EnPresso technology. Therefore, 1 mL of the
identical pre-culture as used for the EnPresso cultivation
was inoculated into 100 mL LB or TB in 1000 mL con-
ical glass flasks and grown at 30°C until the optical dens-
ity at 600 nm reached ~1. Then, IPTG was added to the
culture broth to a final concentration of 1 mM and culti-
vation was continued for 24 h.
Cell growth was monitored by measurement of optical
density in 1 mL cuvettes at 600 nm using a double-beam
UV/Vis spectrophotometer SPECORD® 210 (Analytik Jena).
For pH measurement, 1 mL samples were harvested by
centrifugation and pH was determined from the super-
natant with a micro pH electrode (Mettler-Toledo).
For final harvest, cultures were collected and chilled
on ice for 5 min and centrifuged for 15 min at 6,000 × g
and 4°C. After removal of the supernatant, cell pellets
were either stored at −20°C or subjected to purification
procedure immediately.
For analysis of recombinant protein yield, 1 mL samples
were pelleted for 15 min at 6,000 × g and 4°C. Superna-
tants were discarded and the pellets were frozen at −20°C.
After thawing on ice, pellets were resuspended in xTractor
cell lysis buffer (Clontech Laboratories) supplemented
with endonuclease (Thermo Scientific Pierce) and incu-
bated on ice for 15 min to lyze the cells. Samples were
then centrifuged at 14,000 × g for 5 min to remove cell
debris. Total proteins of the insoluble and soluble frac-
tion from the lysates before centrifugation as well as
soluble protein fractions from the lysate supernatant
after removal of debris and insolubles were analyzed
by SDS-PAGE.
Purification of recombinant proteins
A high-capacity Ni-iminodiacetic acid (IDA) resin was
used for purification of hexahistidine tagged recombin-
ant sdAbs by immobilized metal affinity chromatog-
raphy (IMAC). The gravity-flow-based chromatography
was carried out under native conditions according to the
manufacturer protocol (Clontech Laboratories). Efficient
cell lysis was achieved by addition of 1 mL xTractor cell
lysis buffer (Clontech Laboratories) supplemented with
EDTA-free protease inhibitor cocktail (Roche Diagnostics)
and 25 U endonuclease (Thermo Scientific Pierce) to
200 mg bacterial cell pellet. After incubation on ice for
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20 min for removal of cellular debris, the clarified super-
natant was loaded onto a gravity-flow column containing
1 mL of prepacked resin and incubated at room temper-
ature for 30 min. Before elution of the sdAbs by addition
of elution buffer containing 300 mM imidazole, the
column was washed twice with increasing imidazole
concentrations of 20 and 40 mM. Removal of imidazole
and buffer exchange was achieved by dialysis against
PBS using a cellulose ester membrane with a molecular
weight cut-off of 3.5-5 kDa (Spectrum® Laboratories).
Gel electrophoresis and Western Blot analysis
Denaturing sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) was carried out according
to a standard protocol [61]. For each gel, PageRuler Plus
Prestained Protein Ladder (Thermo Fisher Scientific)
was used as molecular weight ladder standard. After
electrophoresis, proteins were transferred onto a PVDF
membrane (Merck KGaA), subjected to radioluminogra-
phy or stained with PageBlue protein staining solution
(Thermo Fisher Scientific) according to the manufac-
turer’s instructions.
For Western Blot analysis, PVDF membranes were
probed with horseradish peroxidase (HRP)-conjugated
Penta · His antibody (Qiagen) directed against the hexa-
histidine epitope of sdAbs. The primary leporine mono-
clonal EGF Receptor (D38B1) XP® and β-actin (13E5)
antibodies (Cell Signaling Technology), respectively, and a
goat anti-rabbit HRP-conjugated antibody (Sigma-Aldrich)
were used for immunostaining of human EGFR and
β-actin.
Detection of bound conjugates was performed with
the ECL Prime Western Blotting detection reagent (GE
Healthcare) in combination with the STELLA imaging
system (Raytest). In silico quantitative analysis of average
band intensities were performed with the Advanced
Image Data Analysis (AIDA) program (Raytest).
Protein determination
Protein concentration was determined colorimetrically
with the DC Protein Assay (Bio-Rad Laboratories) ac-
cording to the manufacture’s microplate assay protocol
using bovine serum albumin as protein standard.
Estimation of free sulfhydryl and disulfide groups
The fraction of oxidized cysteine residues in the native
sdAb samples was determined as described recently [48]
with slight modifications. Briefly, 50 μg of purified pro-
tein expressed in EnPresso medium were mixed with
300 μL denaturation buffer composed of PBS with 4 M
urea and split into two 150 μL aliquots (Sred and Sox).
After the Sred aliquot was reduced by the addition of
10 mM tris(2-carboxyethyl)phosphine (TCEP), both sampleswere incubated for 1 h at room temperature. In order to
remove the reducing agent, proteins of both samples
were precipitated by acetone. Therefore, five volumes
of cold (−20°C) acetone were added and mixed. After
incubation for 30 min at −20°C, the samples were cen-
trifuged for 5 min at 15,000 × g and the supernatant
was carefully removed. Both pellets were washed with
90% cold acetone, air dried, resuspended in 120 μL de-
naturation buffer containing 1 mM 5,5′-Dithiobis(2-
nitrobenzoic acid) and incubated at room temperature
for 5 min. The absorbance of both samples was mea-
sured photometrical at a wavelength of 412 nm, and
the percentage of oxidized cysteine residues was calcu-
lated using the formula:
100%–100  A412nm Sox½ =A412nm Sred½ 
Thermal unfolding
Thermal unfolding was followed by UV absorbance spec-
troscopy at 280 nm using a double-beam UV/Vis spectro-
photometer SPECORD® 210 (Analytik Jena) equipped
with a Peltier cooled cell holder [62]. Temperature was
increased by 1°C increments at a rate of 1°C/min. A cu-
vette with a 1 cm path length was used, and the protein
concentration was 500 μg/mL in 50 mM potassium
phosphate buffer, 150 mM NaCl, pH 7.4.
Radiolabeling of purified sdAbs
Purified sdAbs were labeled at their carboxy-terminal
hexahistidine epitope with 99mTc-tricarbonyl intermedi-
ate [99mTc(H2O)3(CO)3]
+ at 37°C as described elsewhere
[63,64]. The labeling process of the sdAbs (Rf = 0) was
monitored by radio-TLC using ITLC-SA plates (Merck
Millipore) in combination with a mobile phase of
methanol and 1% concentrated HCl. As control, separ-
ate radio-TLC analyses of [99mTc(H2O)3(CO)3]
+ (Rf = 1)
and 99mTcO4
- (Rf = 0) were performed in the same mo-
bile phase. Evaluation of radio-TLC was carried out using
a radioactivity thin layer analyzer (Rita Star, Raytest).
If necessary, unbound [99mTc(H2O)3(CO)3]
+ was sepa-
rated from the labeled sdAbs by spin filtration using
0.5 mL centrifugal filters with a molecular weight cut-off
of 3 kDa (Merck Millipore).
Radiolabeling of the sdAbs was confirmed by SDS-
PAGE followed by electronic autoradiography of the gel
using a radioluminography laser scanner (Raytest).
In vitro binding studies of sdAbs
Cells were plated in 24 well cell culture microplates
(Greiner Bio-One) at a density of 5*104 cells/0.5 mL/well
(n = 4) and incubated for 48 h prior to addition of radi-
olabeled sdAbs. After 48 h, cells were pre-incubated for
30 min at 4°C before the addition of different concentrations
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cell culture microplates were further incubated for 60 min
at 4°C. Following treatment with radiolabeled sdAbs, cells
were washed three times with PBS in order to ensure
removal of loosely attached proteins from the cellular
membrane. Finally, cell lysis was achieved by the addition
of 1% SDS/0.1 M NaOH and incubation for 30 min at
room temperature with vigorous shaking. The radio-
activity in the cell extracts was quantified using an auto-
mated gamma counter (PerkinElmer Life and Analytical
Sciences). Total protein concentration in cell extracts
was determined as described above.
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